| Abstrakt: |
Researchers from Johns Hopkins University School of Medicine conducted a study on breast cancer, specifically focusing on ductal carcinoma in-situ (DCIS), a pre-invasive form of invasive breast cancer. The study aimed to characterize molecular changes in DCIS to improve risk stratification and understand disease progression. The research identified differences in gene sets between progressing and non-progressing DCIS, highlighting the need for further studies to develop prognostic tools for DCIS. The study concluded that DCIS is a molecularly heterogeneous disease with variable outcomes, emphasizing the importance of investigating intrinsic subtype-stratified characteristics for risk assessment and mitigation of DCIS progression. [Extracted from the article] |
